Inflammation can be a causative factor for carcinogenesis or can result from a consequence of cancer progression. Moreover, cancer therapeutic interventions can also induce an inflammatory response. Various inflammatory parameters are used to assess the inflammatory status during cancer treatment. It is important to select the most optimal biomarker among these parameters. Additionally, suitable biomarkers must be examined if there are no known parameters. We briefly reviewed the published literature for the use of inflammatory parameters in the treatment of patients with cancer. Most studies on inflammation evaluated the correlation between host characteristics, effect of interventions, and clinical outcomes. Additionally, the levels of C-reactive protein, albumin, lymphocytes, and platelets were the most commonly used laboratory parameters, either independently or in combination with other laboratory parameters and clinical characteristics. Furthermore, the immune parameters are classically examined using flow cytometry, immunohistochemical staining, and enzymelinked immunosorbent assay techniques. However, gene expression profiling can aid in assessing the overall peri-interventional immune status. The checklists of guidelines, such as STAndards for Reporting of Diagnostic accuracy and REporting recommendations for tumor MARKer prognostic studies should be considered when designing studies to investigate the inflammatory parameters. Finally, the data should be interpreted after adjusting for clinically important variables, such as age and cancer stage.
INTRODUCTION
Inflammatory response, which promotes the healing of injured tissues, is a physiological defense mechanism against foreign substances. Inflammation can be a causative factor in cancer development or can result from a consequence of cancer progression. Additionally, inflammation can be induced by cancer interventions and/or by the cancer-associated complications and subsequently affect the tumor recurrence, progression, and metastasis [1] . It is important to determine the molecular players involved in the inflammatory response against cancer cells to assess the inflammation status and to devise the best therapeutic strategy [2]. [4] [5] [6] Immunosuppressive medication [12] Chronic disease [16] Open surgery vs MIS [21] [22] [23] [24] Anesthesia, analgesia [30] [31] [32] Morbidity and mortality [56] [57] [58] [59] [60] [61] [62] [63] Recurrence [68] [69] [70] [71] [72] Age [7, 8] Nutritional status [13] Cancer progression [17] Major vs minor surgery [1, 25] Fast track protocol [33] [34] [35] Infection [64, 65] Survival [12, 26, [73] [74] [75] [76] [77] [78] [79] [80] [81] Obesity [3, [9] [10] [11] Smoking [14] Psychiatric disease [18] Emergency surgery [26, 27] Transfusion [36, 37] Prediction of neoadjuvant response [66,67] Exercise [15] Ischemia [19] Surgical stress [28, 29] Nutritional support* [38-44] Sepsis [20] Steroid and other immune modulators [25, [45] [46] [47] [48] [49] [50] Adjuvant/neoadjuvant treatment [51] [52] [53] NSAID [54] Statin [55] MIS = minimally invasive surgery; NSAID = non-steroid anti-inflammatory drug. *Includes enteral, parenteral, and immune-enhancing nutrition. chromosomes and variations in sex hormones [4] . Estrogen promotes T helper cell type 2 (Th2) and suppresses T helper cell type 1 (Th1) immune responses, whereas testosterone suppresses the Th2 immune response [5] . The Th1 immune responses are cell-mediated responses that target the intracellular pathogen, whereas Th2 responses are antibodymediated responses that target the extra-cellular pathogen. The analysis of differential immune response between the genders revealed that women have a lower risk of microbial infections and higher prevalence of autoimmune disease, whereas men have a higher susceptibility to systemic inflammatory response syndrome or infectious complications after surgery [6] . Age is also an important clinical parameter. The body's ability to distinguish between self and non-self cells decreases with age. Hence, decreased number of immune cells and weakened immune function associated with aging increase the susceptibility to malignancies and reactivation of chronic infections among aged individuals. Thus, several studies have evaluated the postoperative outcomes for elderly patients [7, 8] . Obesity, which is generally measured by BMI, is associated with impaired immune function [9] , inflammation [10] , and complications following treatment interventions [11] .
Other factors that may affect the inflammatory response and clinical outcomes include behaviorand disease-related characteristics, such as immunosuppressive medication usage [12] , nutritional status [13] , smoking status [14] , exercise habits [15] , presence of chronic disease [16] , cancer stage [17] , psychiatric condition [18] , and presence of ischemia [19] or sepsis [20] .
Intervention factors
Among the various therapeutic interventions, surgery is the most invasive intervention. The incision size or resection extent is directly correlated with the degree of surgical trauma. Hence, several studies are focused on developing novel surgical techniques that are associated with less surgical trauma and exhibit similar therapeutic efficacy. In the last few decades, comparative efficacy of open and laparoscopic surgery has been well studied [21] . The advantages of laparoscopic surgery include decreased surgical trauma and attenuated inflammatory response. The Th1/Th2 ratio is modulated to favor a decreased inflammatory response and decreased concentration of acute phase markers [22, 23] . Recently, minimally invasive surgical procedures, such as reduced port laparoscopy and robotic surgery have been used to reduce the inflammatory response associated with open surgery [23, 24] .
The inflammatory response resulting from surgical intervention correlates with surgical trauma and is easy to predict. However, inflammatory responses resulting from other medical interventions are diverse and difficult to predict. Anesthetic techniques affect not only postoperative recovery but can also potentially impair the survival outcomes due to the suppression of inflammation [30, 82, 83] . Regional or epidural anesthesia is reported to be a factor that mitigates surgery-induced immunosuppression [31, 32] . Moreover, peri-operative management [33] [34] [35] , transfusion strategy [36, 37] , and pain management [32] are reported to considerably influence the inflammatory response.
Nutritional supplements, such as glutamine and arginine are used to enhance the immune response (referred to as immunonutrition) [38, 39] , while probiotics are used for perioperative modulation of the gut microbiome [40, 41] . Nutrional supplements and probiotics have been extensively studied to determine their effect on the immune response and clinical outcomes. However, it is difficult to evaluate the effect of nutritional interventions on well-nourished patients. The nutritional interventions are most effective in patients exhibiting malnourishment [84, 85] .
Finally, steroids are one of the most well studied drugs that are used to attenuate the immune response. Preoperative steroid administration is reported to markedly decrease systemic inflammatory cytokine release and improve the postoperative clinical course of patients, without adverse effects on immunity [45, 46] . The immune modulators, such as dendritic cell-activated cytokine-induced killer cells [47] , interleukin (IL)-2 [48], neutrophil elastase inhibitors [49] , protease inhibitors [50] , and recombinant human granulocyte colonystimulating factor [25] have been studied to determine their effectiveness during the periintervention period.
Outcomes
The most classical clinical outcomes measured following therapeutic interventions, such as surgery, chemotherapy, or radiotherapy are complication rates and recovery time in shortterm [61] , and survival without unfavorable events in long-term [71] . Additionally, some inflammation parameters including tumor-infiltrating lymphocytes or composite scores can be used for predicting the inflammation response following neoadjuvant chemo-radiation therapy [64, 65] or for anticipating an infection [66] following an intervention.
APPROACHES FOR EVALUATING INFLAMMATORY PARAMETERS Laboratory parameters
Historically, laboratory values are used to assess the inflammatory status of the patients (Table 2) [3, 17, 23, 26, 34, 35, 38, 39, 42, 44, 50, 59, 62, 66, 69, 71, [73] [74] [75] [76] [77] [78] [79] 84, [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] . Laboratory parameters are economical to evaluate, easily measurable, repeatable, and ready to use in daily clinical practice. Among the various laboratory parameters, acute phase protein levels are the most relevant to determine the inflammatory status of patients. The levels of positive acute phase proteins increase, whereas those of negative acute phase proteins decrease during inflammation [107] . C-reactive protein (CRP) and albumin are the most commonly used positive and negative acute phase proteins, respectively. CRP is secreted from the liver and the CRP levels increase upon secretion of IL-6 by macrophages and T-cells. Although meta-analyses have revealed limited diagnostic value of CRP for diagnosing postoperative complications [108, 109] , CRP level is useful during follow-up as it has a short half-life.
The predominant protein in the blood serum is albumin. Albumin carries water-insoluble molecules necessary for various metabolic processes. Although albumin is reported to be a negative acute phase protein, hypoalbuminemia does not represent an increased inflammatory status in patients [110] . Hence, albumin level is used independently or in combination with other laboratory values to assess the nutritional status in patients [100] .
The combination of CRP and albumin has been extensively studied for the prediction of survival [106, 111] , tumor recurrence [70, 71] , peri-operative mortality [58] , and specific outcomes, such as central venous catheter-related bloodstream infection [66] . The predictive value of CRP and albumin combination is not conclusive due to the heterogeneity in results reported by different studies. However, the CRP and albumin levels are the most sensitive and reliable biomarkers among the various inflammation-based scores [98, [111] [112] [113] .
Currently, CRP, albumin, lymphocytes, or platelets are used in combination to predict the surgical outcomes. Fig. 1 shows the relationship among these parameters. However, the use of combinations of these four parameters without accounting for the clinical parameters can be misleading as these 4 parameters are not independent but associated with patient characteristics, such as age and cancer stage. Thus, combined parameters based on albumin may lose their predictive value after adjustment with patient characteristics [3, 114] . As shown in Fig. 2 , there is a correlation between albumin level, age, and cancer stage [115] .
Immune parameters

Immune cells
Assessment of immune cells and cytokines is necessary to evaluate the immune response in patients (Table 3) [1, 3, 13, 14, 18, 20, 22, 25, 27, 29, 30, 31, 34, 35, 39, [42] [43] [44] 47, [50] [51] [52] [53] [54] 60, 63, 67, 72, 79, 80, 81, [85] [86] [87] [88] 90, 91, 93, 95, 97, 103, [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] . The innate immune response is rapid and does not require prior exposure to an antigen. This general, non-specific, and first-line defense system against foreign substances is mediated by the natural killer (NK) cells. In response to injury, macrophages and mast cells are the first host tissue cells that are activated, which subsequently coordinate the immune response. The adaptive immune cells mainly consist of B and T lymphocytes. The analysis of complete blood count (CBC) provides the crude numbers of neutrophils, granulocytes, lymphocytes, and platelets. However, evaluating the lymphocyte subpopulations of dendritic cells and T-cells is more complicated and requires flow cytometric analysis. The T-cells comprise cytotoxic T-cell and helper T-cell subpopulations, which can be further classified as Th1, Th2, Th17, and regulatory T cells. Cancer recurrence can be predicted by phenotyping and functional assay of lymphocytes from the peripheral blood and tumor lysate [68] . If fresh blood is not available, the immune status of tumor tissues can be evaluated by immunohistochemical staining. The advantage of using paraffin-embedded tissue blocks is that the long-term outcome of the treated patients is already known. The tumor microenvironment is assessed by evaluating the lymphocytes [133] [134] [135] , tumor-associated macrophages [72] , and myeloid-derived suppressor cells [136] .
Cytokines
The immune cells communicate with each other through signaling molecules or cell-to-cell communication, which involve toll-like receptors, B and T cell receptors and the complement system [137, 138] . However, majority of the immune cells communicate through the secretion of cytokines. Cytokines are a category of cell-signaling proteins that regulate various immunological functions. Various proteins, such as lymphokines (produced by lymphocytes), monokines (produced by monocytes), chemokines (regulate chemotactic activities between cells), interferons (involved in the antiviral activity), and interleukins function as cytokines. Several cytokine classifications were proposed based on the Th1/2 axis [139, 140] Among these classifications, the functional classifications (Th1/2) and receptor structures is the most relevant grouping method ( Table 4 ) [144] . The functional classification is widely used in clinical and experimental practice and categorize the cytokines based on their involvement in cellular immune responses (Th1) and antibody-mediated responses (Th2). The Th1 response is the principal immune mechanism underlying cellular immunity. Cellmediated immune response includes activation of monocytes and cytotoxic T lymphocytes against virus-infected cells, intracellular parasites, intracellular bacteria, and tumors [145] . The critical cytokines involved in type I response are interferon-gamma (IFN-γ) and IL-12. The mechanism underlying humoral immunity involves type II response. Humoral immune response includes the activation of eosinophils, mast cells, and B lymphocyte proliferation and differentiation. The key cytokines involved in mediating type II response are IL-4 and IL-10. Type II response is immunosuppressive and is observed after extensive injury in patients with cancer undergoing surgery. IL-4 and IL-10 inhibit type I response, whereas IFN-γ inhibits type II response. As these 2 response mechanisms may inhibit each other, the ratio of the major molecular players involved in type I and type II responses (the ratio of IFN-γ or IL-12/ IL-4 or IL-10) can be useful biomarkers [30, 31, 121, 122, 143, 145] . Oxidative stress-antioxidant capacity [87] NK = natural killer; HLA-DR = human leukocyte antigen-DR isotype; TNF = tumor necrosis factor; INF, interferon; Th = T helper; IL = interleukin; Ig = immunoglobulin; MCP-1 = monocyte chemoattractant protein-1; DAMP = damage-associated molecular patterns; TLR = Toll-like receptors; RT-PCR = real-time polymerase chain reaction. 
Gene expression
Flow cytometry and enzyme-linked immunosorbent assay are used for classical hypothesisdriven studies. These are confirmatory techniques that are specific for the selected parameters ( Fig. 3) [23, 24, 33, [45] [46] [47] 86, 122, 123, 125, [146] [147] [148] [149] [150] [151] [152] . However, measuring only selected immune responses does not provide information on the global changes associated with complex immune response. The inflammatory response status can be evaluated using gene expression. A study on patients with colon cancer undergoing surgery demonstrated that the genes associated with antigen presentation, general T-cell receptor signaling, and granzyme-B encoding for NK and CD8 + T-cells are downregulated [153] . Additionally, the study revealed that the genes encoding cytokines (IL-1B, IL-6, tumor necrosis factor [TNF], and IL-10), CRP, growth factor, and matrix metalloproteinase were upregulated [153] . This indicated downregulation of T-cell receptor signaling, antigen presentation, and NK cell activity and promotion of metastases, growth, and angiogenesis. The strength of this highthroughput study enables us to assess the "genomic storm" of peri-operative changes in gene expression. The gene expression changes indicate not only immune system activation but also the inability to maintain homeostasis. Another study demonstrated the downregulation of differentiation/clonal expansion of T cytotoxic cell and T-cell surface markers and upregulation of IL-18 and IL-10 signaling pathways [154] .
It is intriguing that transcriptomic data from a bulk tumor can be used to predict the status of immune cell infiltration. Fig. 4 illustrates a heatmap of 22 types of immune cell infiltration inferred from The Cancer Genome Atlas stomach adenocarcinoma gene expression cohort [155] . Cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) is a deconvolution algorithm that uses a set of reference gene expression values to support the vector regression inference immune cell types in data from mixed cell types of bulk tumor samples [156] .
Guidelines
Effective data collection is necessary to identify the relevant parameters associated with the inflammatory response. REporting recommendations for tumor MARKer prognostic studies (REMARK) and STAndards for Reporting of Diagnostic accuracy studies (STARD) provide suggested guidelines as checklists to supply relevant information necessary for the design and reporting of prognostic markers and diagnostic accuracy [157, 158] . STARD focused on the preciseness of a parameter compared to the gold-standard. The prediction of complications based on preoperative or immediate postoperative laboratory values provides a good example of STARD guidelines [108, 159] . REMARK guidelines are used to predict the survival of patients undergoing a test or treatment. A preoperative neutrophil-to-lymphocyte ratio predicting long term survival would be an example of application of REMARK guidelines [77] . As REMARK guidelines are related to survival, it is important to assess time-to-event and associated clinical factors such as age, sex, and disease status. These two guidelines share the essential factors of describing a good study and defining other unique requirements. We compared the checklists of STARD and REMARK guidelines to guide good study design and data analysis ( Table 5 ).
Interpretation of data
A prerequisite for the identification of a novel biomarker is the valid interpretation of data. We suggest that three issues must be elaborated during the data interpretation. First, inherent characteristics of patients, such as age, sex, and disease status, should be adjusted using a multivariate analysis for assessing the value of inflammatory parameters. This is to prevent the misinterpretation of data. The level of albumin, which is required for calculation of PNI, is highly correlated with age and cancer stage, such that the diagnostic value of PNI decreases after adjustment [3, 115] . Second, most of the inflammatory parameters exhibit continuous variation. For any regression analysis, it is always preferable to treat continuous parameters as continuous. However, these parameters are converted to categorical values to enter into regression models in most studies. An arbitrary decision for the cut-off values may result in a misinterpretation of data and hinders their routine use in clinical practice. Third, a value could be interpreted differently in the context of the inflammatory response. Skewing Th1/Th2 immune function, proportion of regulatory T-cells among helper T-cells, and a sequential change of parameters following surgery are good examples. 
INFLAMMATION AND GASTRIC CANCER
Various aspects of the relationship between inflammation and gastric cancer treatment have also been studied. Microenvironment generated by unresolved inflammation is involved in the pathogenesis of non-cardia gastric cancer [160] . The host factors, such as age, obesity, and nutritional status are reported to be associated with the outcome of gastric cancer treatment [161, 162] . Minimally invasive surgery has been widely used and several studies, including randomized trials have demonstrated the higher efficacy of laparoscopic and robot-assisted surgeries compared to open surgery [163, 164] . Anesthesia techniques and perioperative nutritional support have enhanced postoperative recovery after the guidelines for gastric cancer surgery were published [165, 166] . Laboratory and immune parameters are reported to be a predictor of outcomes in several studies, including our earlier studies [3, 101, 115] .
Inflammation is the common condition that was evaluated in all these studies. The purpose of cancer research should not only include killing cancer cells but also patient care. However, there are limited studies that have comprehensively evaluated the correlation between highquality clinical parameters, immune cells, and cytokines. We believe that sharing insights of inflammation during the disease process and biomedical literacy of clinicians in molecular, genetic, and immune mechanisms will change the way of providing care to patients with gastric cancer in the future [153, 155] .
CONCLUSIONS
There has been an increased interest in predicting short-and long-term treatment outcomes. To show a significant difference during the hypothesis test, study aim, selection of parameters, and interpretation of results should be carefully performed, as recommended in this review. Although not discussed here, issues associated with the sources of examined material (peripheral blood, tumor lysate, or tumor draining vein) and timing of examination 
